Drug Profile
Research programme: menstrual blood stem cell therapies - Cryo-Cell International
Alternative Names: Human menstrual blood-derived mesenchymal stem cells - Cryo-CellLatest Information Update: 24 Jul 2013
Price :
$50
*
At a glance
- Originator Cryo-Cell International
- Developer Cryo-Cell International; Cryopraxis; Monash University
- Class Gene therapies; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Endometriosis; Multiple sclerosis; Urinary incontinence
Most Recent Events
- 24 Jul 2013 No development reported - Preclinical for Endometriosis in Brazil (Parenteral)
- 24 Jul 2013 No development reported - Preclinical for Multiple sclerosis in Australia (Parenteral)
- 24 Jul 2013 No development reported - Preclinical for Urinary incontinence in Brazil (Parenteral)